Results of a planned interim toxicity analysis with trimodality therapy, including carboplatin AUC = 4, paclitaxel, 5-fluorouracil, amifostine, and radiation for locally advanced esophageal cancer: preliminary analyses and treatment recommendations from the North Central Cancer Treatment Group

Table 2

Patient	Amifostine dose received (%)*	Neoadjuvant chemotherapy dose received (%) 1^stcycle/2^ndcycle*	Disease Status
1	31	81/75	CR**
2	7	71/57	CR
3	16	64/11	PR***
4	27	100/26	PR
5	73	100/100	CR
6	24	52/3	CR
7	63	62****	PR
8	87	86****	dead
9	7	91/28	CR
10	67	72/79	CR